You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-RNA polymerase II CTD repeat YSPTSPS antibody (ab52202)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-RNA polymerase II CTD repeat YSPTSPS antibody
See all RNA polymerase II CTD repeat YSPTSPS products (17) ...

Description

Rabbit polyclonal to RNA polymerase II CTD repeat YSPTSPS

Specificity

ab52202 detects endogenous levels of total RNA polymerase II protein.

Tested applications

WB, IHC-P, ELISAmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic non-phosphopeptide derived from human RNA polymerase II CTD repeat YSPTSPS around the phosphorylation site of serine 5 (P-T-S-P-S).

Positive control

WB: extracts from COS7 cells treated with EGF (200ng/ml, 30min). IHC-P: human breast carcinoma tissue.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS, 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - RNA polymerase II antibody (ab52202)Western blot - RNA polymerase II antibody (ab52202) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - RNA polymerase II antibody (ab52202)Immunohistochemistry (Paraffin-embedded sections) - RNA polymerase II antibody (ab52202) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab52202 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. Acts as a RNA-dependent RNA polymerase when associated with small delta antigen of Hepatitis delta virus, acting both as a replicate and transcriptase for the viral RNA circular genome.

Sequence similarities

Belongs to the RNA polymerase beta' chain family.

Post-translational
modifications

The tandem 7 residues repeats in the C-terminal domain (CTD) can be highly phosphorylated. The phosphorylation activates Pol II. Phosphorylation occurs mainly at residues 'Ser-2' and 'Ser-5' of the heptapeptide repeat. The phosphorylation state is believed to result from the balanced action of site-specific CTD kinases and phosphataes, and a "CTD code" that specifies the position of Pol II within the transcription cycle has been proposed.
Dephosphorylated by the protein phosphatase CTDSP1.
Ubiquitinated by WWP2 leading to proteasomal degradation.
Methylated at Arg-1810 by CARM1. Methylation occurs only when the CTD is hypophosphorylated, and phosphorylation at Ser-1805 and Ser-1808 prevent methylation (in vitro). It is assumed that methylation occurs prior to phosphorylation and transcription initiation. CTD methylation may facilitate the expression of select RNAs.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP24928 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • MGC75453 antibody
  • B220 antibody
  • DNA directed RNA polymerase II A antibody
  • DNA-directed RNA polymerase II largest subunit antibody
  • DNA-directed RNA polymerase II subunit A antibody
  • DNA-directed RNA polymerase II subunit RPB1 antibody
  • DNA-directed RNA polymerase III largest subunit antibody
  • POLR2A antibody
  • POLRA antibody
  • Polymerase (RNA) II (DNA directed) polypeptide A 220kDa antibody
  • RNA polymerase II subunit B1 antibody
  • RNA-directed RNA polymerase II subunit RPB1 antibody
  • RPB1 antibody
  • RPB1_HUMAN antibody
  • RPB220 antibody
see all

Anti-RNA polymerase II CTD repeat YSPTSPS antibody images:

  Western blot - RNA polymerase II antibody (ab52202)

Western blot - RNA polymerase II antibody (ab52202)

All lanes : Anti-RNA polymerase II CTD repeat YSPTSPS antibody (ab52202) at 1/500 dilution

Lane 1 : COS7 cells treated with EGF (200ng/ml, 30min), without immunising peptide
Lane 2 : COS7 cells treated with EGF (200ng/ml, 30min), with immunising peptide


Predicted band size : 217 kDa
Observed band size : 217 kDa

  Immunohistochemistry (Paraffin-embedded sections) - RNA polymerase II antibody (ab52202)

Immunohistochemistry (Paraffin-embedded sections) - RNA polymerase II antibody (ab52202)

Immunohistochemical analysis of RNA polimerase II expression in paraffin embedded human breast carcinoma tissue using ab52202 at 1/500.
Left: sample without immunising peptide.
Right: sample with immunising peptide (negative control).

References for Anti-RNA polymerase II CTD repeat YSPTSPS antibody (ab52202)

ab52202 has not yet been referenced specifically in any publications.

Publishing research using ab52202? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"